Component: (Network and Table)
Network
00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
(http://www.aclaristx.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001557746 (http://www.sec.gov/CIK)
Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Cash Flows
 
 
 
Cash flows from operating activities:
 
 
 
Net loss
(48,079,000) 
(20,563,000) 
(8,517,000) 
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Depreciation expense
120,000  
90,000  
12,000  
Stock-based compensation expense
6,104,000  
891,000  
27,000  
Write-down of property and equipment held for sale
216,000  
289,000  
 
Non-cash charges related to Vixen acquisition
2,784,000  
  
Changes in operating assets and liabilities:
 
 
 
Prepaid expenses and other assets
(8,000) 
(1,269,000) 
(152,000) 
Accounts payable
1,810,000  
(359,000) 
819,000  
Accrued expenses
2,450,000  
552,000  
175,000  
Net cash used in operating activities
(34,603,000) 
 
(20,369,000) 
 
(7,636,000) 
 
Cash flows from investing activities:
 
 
 
Purchases of property and equipment
(232,000) 
(507,000) 
(417,000) 
Purchases of marketable securities
(148,764,000) 
(82,513,000) 
(5,035,000) 
Proceeds from sales and maturities of marketable securities
87,093,000  
6,069,000  
3,673,000  
Net cash used in investing activities
(61,903,000) 
 
(76,951,000) 
 
(1,779,000) 
 
Cash flows from financing activities:
 
 
 
Proceeds from issuance of common stock in connection with private placement, net of issuance costs
18,547,000  
  
Proceeds from follow-on public offering, net of issuance costs
98,158,000  
  
Proceeds from initial public offering, net of offering costs
 
56,550,000  
 
Proceeds from issuance of convertible preferred stock, net of issuance costs
 
39,864,000  
10,584,000  
Proceeds from the exercise of employee stock options
121,000  
  
Net cash provided by financing activities
116,826,000  
 
96,414,000  
 
10,584,000  
 
Net increase (decrease) in cash and cash equivalents
20,320,000  
 
(906,000) 
 
1,169,000  
 
Cash and cash equivalents at beginning of period
9,851,000  
10,757,000  
9,588,000  
Cash and cash equivalents at end of period
30,171,000  
 
9,851,000  
 
10,757,000  
 
Supplemental disclosures of non-cash investing and financing activities:
 
 
 
Additions to property and equipment included in accounts payable
11,000  
2,000  
91,000  
Fair value of stock issued in connection with Vixen acquisition
2,355,000  
  
Offering costs included in accounts payable
250,000  
  
Accretion of convertible preferred stock to redemption value
 
1,764,000  
2,054,000  
Fair value of preferred stock purchased put option on date of issuance
  
1,039,000